Voyager Therapeutics, Inc. (15) | License Agreements (2)
- First Amendment to Amended and Restated Option and License Agreement with Genzyme Corporation, dated September 20, 2020 (Filed With SEC on November 9, 2020)
- Amended and Restated Option and License Agreement, by and between Voyager Therapeutics, Inc. and Genzyme Corporation, dated June 14, 2019 (Filed With SEC on August 9, 2019)
